Opportunity
DIBBS #SPE2DP-26-T-2972
DLA Procurement of Guaifenesin Extended-Release Tablets, 600mg, for Fort Bragg
Posted
April 20, 2026
Respond By
April 27, 2026
Identifier
SPE2DP-26-T-2972
NAICS
424210
This procurement opportunity from the Defense Logistics Agency Troop Support Medical Supply Chain Pharmacy FSA seeks Guaifenesin Extended-Release Tablets for military use: - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - OEMs and Approved Vendors: - Reckitt Benckiser LLC (NDC63824-0008-50) - The Harvard Drug Group, L.L.C. (NDC00904-6986-04) - Products Requested: - Guaifenesin Extended-Release Tablets, 600mg, bottles of 500 tablets - NSN: 6505-01-340-5446 - Quantity: 10 bottles - Unit of Issue: Bottle (500 tablets per bottle) - Part Numbers: NDC63824-0008-50 (Reckitt Benckiser), NDC00904-6986-04 (Harvard Drug Group) - Unique or Notable Requirements: - Delivery required within 20 days to Fort Bragg, NC - Packaging must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1 - Minimum shelf life of 31 months at delivery (36 months total shelf life) - Compliance with DFARS and FAR clauses, including cybersecurity and hazardous material handling
Description
GUAIFENESIN EXTENDE (QTY: 10, NSN: 6505-01-340-5446, Purchase Request: 7016391340) Approved Sources: - CAGE: 0MWS8, Part No: NDC63824-0008-50, Company: RECKITT BENCKISER LLC - CAGE: 1LEZ0, Part No: NDC00904-6986-04, Company: THE HARVARD DRUG GROUP, L.L.C.